AI-generated summary
The authors tested whether low-level laser light at 670 nm, combined with cisplatin or zoledronic acid, changed cell viability in primary human fibroblasts and in a head and neck squamous cell carcinoma cell line in vitro. They report that laser treatment increased viability in both cell types and lowered viability at the highest drug concentrations, with cisplatin effects in cancer cells at every concentration. The study was conducted in cell cultures only, so the findings are limited to laboratory conditions.
- Who or what was studied
- Primary human fibroblasts and the UM-SCC-3 head and neck squamous cell carcinoma cell line, studied in vitro
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study was conducted in vitro with cell lines only, and the authors state that conclusions are limited to the study's scope.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.